We use cookies for a better user experience. Read our Privacy Policy

I Agree

Veterinary Dermatology Drugs Market

Veterinary Dermatology Drugs Market (Product Type: Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs, and Others; Mode of Administration: Topical, Oral, and Injectable; Animal Type: Large Animals and Small Animals; and Indication: Infectious Diseases, Skin Cancer, Autoimmune Skin Diseases, Parasitic Infections, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Harmful, Deadly Skin Infections Common Cause of Death in Animals

Veterinary dermatologists are notably qualified in diagnosing and operating infectious skin diseases such as bacterial, fungal, and viral in animals. Many animals across the world suffer from severe diseases including parasitic skin diseases, dander-related skin disorders, alopecia, intrinsic skin infections, autoimmune skin diseases, mild and harmful skin cancer, hormonal-related skin diseases, and other internal causes for skin abnormalities. Advancements in medical devices and increasing research sources for veterinary dermatologists to diagnose and treat such severe diseases are proving beneficial for pets, pet owners, and other animals. Thus, the rise in veterinary visits is contributing to the growth of the global veterinary dermatology drugs market during the forecast period.

Presently, more than 20% of all animal veterinary meetings are associated with dermatological problems. The most commonly diagnosed dermatological conditions are allergies, otitis externa, seborrhoeic dermatitis, and surface pyoderma. The market still demands tremendous improvement in the animal dermatology sector and hence, there is a progress in discovering new drugs for the veterinary service. With safety and efficacy studies being developed, there is notable advancements made for equine lameness and the manufacturers are focusing on increasing the production and distribution of the drugs, helping horses globally. Recently, innovations in equine dermatological drugs are helping with common diseases such as skin inflammation. fungal infection, or an infectious bacterium in horses. As disorders are very common in horses across the world, there is a heavy demand for the veterinary dermatology drugs market and is expected to grow in the upcoming future.

veterinary dermatology drugs market infographic

To know the scope of our report Get a Sample on Veterinary Dermatology Drugs Market

COVID-19 Pandemic Impacting Animal Care in Most Regions

The effects of the COVID-19 pandemic on the veterinary profession has been unexpected, far-reaching, and diverse. Across many countries, veterinary dermatology practices have made enormous changes to assure patients continue to receive crucial veterinary care, and new safety standards are achieved to protect staff and clients. Veterinary experts have implemented a variety of operational strategies and prudent measures to continue giving veterinary care, while restricting the spread of the coronavirus and prioritizing safety.

The COVID-19 pandemic continues its attack on the world and the veterinary profession, and it is expected to affect the global veterinary dermatology drugs market until the end of 2021. However, as precautionary measures, clients are being asked to wait in vehicles during animal exams and treatment. Other operational developments include contactless payment processing, transferring patient data online, and drive-thru pick-up and drop-off. However, due to constraints in the supply chain and manufacturing units due to limited workforce and stringent regulations, the market is experiencing slow growth amidst the pandemic. Nevertheless, rapid distribution of vaccines and improved medical care are expected to drive the global veterinary dermatology drugs market growth rate shortly.

Get a glimpse of the in-depth analysis through our Report Brochure

Antifungals for Animals to Witness Heavy Demand

As compared to some common diseases in humans and animals such as mycoses, mycotic diseases in animals have gained much less consideration. This is unusual, as dermatophytes acting as agents of infectious diseases in animals is one of the oldest recognized disorders in animals. The dermatophytes are responsible for several zoonotic infections, and it is estimated to account for 80% of human skin diseases through animals. However, recent innovations in animal medications and treatments are efficient in the cure of such diseases. Moreover, manufacturers are focusing on research and development to avoid dermatophytes and infections related to it. These innovations are likely to attract various pet owners to the veterinary dermatology drugs market during the forecast period.

Presently, numerous antifungal drugs are used to treat skin diseases in animals. Based on the fungus and animals, the veterinarian prescribes the drug for the treatment. Although griseofulvin is the single antifungal recommended for systemic treatment by the Food and Drug Administration (FDA) for veterinary use, a variety of systemic antifungals are available for use in veterinary medicine. With rise of generic formulations, various cost-efficient drugs can be found in the current market. The appearance of immunity in fungal organisms has influenced various producers for the development of newer antifungals such as itraconazole, fluconazole, voriconazole, and posaconazole. The effective and improved treatment options are driving the global veterinary dermatology drugs market in the near future.

Rising Pet Adoption, Growing Care for Animals Encourage Advancements in Dermatology Drugs

The veterinary dermatology drugs market has witnessed a meaningful surge over the years, due to the rising awareness concerning veterinary care. Growing urbanization and increasing number of pet animals are anticipated to influence the growth of the veterinary dermatology drugs market. The rising ubiquity of atopic dermatitis among animals is significantly demanding better veterinary drugs. The world, especially guardians and owners of pets, is learning about veterinary skin disorders, treatment options, and various government initiatives to increase farm animal productivity. In addition, increasing population of companion animals and compliance to spend for their healthcare are assisting in the global market growth during the forecast period. The global veterinary dermatology drugs market is projected to expand at a moderate CAGR from 2021 to 2031.

North America holds the major share of the veterinary dermatology drugs market, owing to the high prevalence of pruritus, sores, alopecia, masses, eruptions, scales, seborrhea, pustules, and draining tracts in animals, and is expected to continue its dominance during the forecast period. Followed by North America, Europe is expected to hold a significant position in the veterinary dermatology drugs market, due to the various new dermatological association in the European region, which is increasing awareness about skin diseases in animals. Furthermore, this market in Asia Pacific is likely to be driven by the increased adoption of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region.

veterinary dermatology drugs market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

The expanding awareness about available skin treatment choices and the growing incidences of skin problems such as atopic dermatitis are driving the global veterinary dermatology drugs market. Governments of various nations are taking initiatives to improve productivity of farm animals by investing in veterinary drugs. As ointments and creams are easily accessible and simple to use, they are expected to dominate the skincare segment of the veterinary dermatology drugs market. The market is currently witnessing a slowdown due to strict government regulations due to the ongoing pandemic. However, with veterinarians taking proper measures and providing contactless services, the global veterinary dermatology drugs market is projected to overcome the current restraints in the upcoming future.

Veterinary Dermatology Drugs Market: Overview

  • The global veterinary dermatology drugs market was valued over US$ 3.6 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Increase in medical and diagnostic capabilities for companion animals and rise in ownership of companion animals are anticipated to propel the global veterinary dermatology drugs market during the forecast period. Key industry developments, including partnerships, mergers & acquisitions, and collaborations are expected to fuel the growth of the global veterinary dermatology drugs market.
  • Increase in longevity of pet animals due to improvements in diagnostics, greater emphasis on wellness and prevention by veterinarians, and enhanced nutrition have expanded the use of veterinary dermatology drugs
  • Pet ownership is rising in developed and emerging markets, which, in turn, increases expenditure on companion animals globally
  • In 2013, around 62% of the U.S. households owned a companion animal (excluding horses) i.e., around 72.9 million homes. Brazil, China, India, Mexico, and Russia are among the top countries with high growth rate in terms of companion animal ownership.
  • Changes in the ecology of parasite habitats, climate change, increase in vector-host interactions, introduction of foreign species in endemic areas, and rise in travel by companion animal owners could potentially be responsible for growth of the geographical spreading of parasites and high risk of vector-borne infection outside traditional endemic areas. These factors drive the global veterinary dermatology drugs market.
  • Incidence of emerging diseases such as helminth parasites and protozoal parasitic diseases is increasing. Development of better methods such as molecular diagnostics to detect and combat these diseases on time is projected to propel the global veterinary dermatology drugs market.

Veterinary Dermatology Drugs Market: Segmentation

  • The global veterinary dermatology drugs market has been segmented based on product type, mode of administration, animal type, indication, and region
  • In terms of product type, the global veterinary dermatology drugs market has been classified into antifungal drugs, antibacterial drugs, antiparasitic drugs, and others. The antibacterial drugs segment dominated the global veterinary dermatology drugs market in 2020, owing to high prevalence of bacterial infection among animals and rise in usage of antibacterial drugs.
  • Based on mode of administration, the global veterinary dermatology drugs market has been categorized into oral, topical, and injectable. The topical segment captured the largest market share in 2020, as it is among the oldest and most efficient mode of administration of drugs to control inflammatory and immune-mediated skin disorders.
  • In terms of animal type, the global veterinary dermatology drugs market has been bifurcated into large animals and small animals. The large animals segment has been split into equine, bovine, and others. The small animals segment has been segregated into cats, dogs, and others.
  • Based on indication, the global veterinary dermatology drugs market has been divided into infectious diseases, skin cancer, autoimmune skin diseases, parasitic infections, and others. The infectious diseases segment accounted for significant share of the market in 2020, as infectious diseases are the most common type of veterinary dermatology conditions in companion as well as livestock animals.

Veterinary Dermatology Drugs Market: Regional Segmentation

  • In terms of region, the global veterinary dermatology drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to be a highly attractive market for veterinary dermatology drugs from 2021 to 2031. High revenue from the region can be attributed to increase in government and private funding and large volume of tests performed. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher, which further propels the market.
  • The veterinary dermatology drugs market in Asia Pacific is expected to be driven by high adoption of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region

Veterinary Dermatology Drugs Market: Major Players

  • Key players operating in the global veterinary dermatology drugs market are
    • Merial, Zoetis, Inc.
    • Ceva Sante Animale
    • Vetmedica
    • IDEXX Laboratories
    • Vetoquinol S.A.
    • Virbac S.A.
    • Bayer Animal Health
    • Boehringer Ingelheim
    • Elanco
    • Novartis Animal Health
    • SAVAVET
    • Toray Industries
    • AB Science
  • These players focus on adopting various strategies to expand product offerings and strengthening geographic presence across the globe. Technological advancements, mergers & acquisition, expansion of product portfolio, and rise in research & development are strategies adopted by companies to expand market presence.

Veterinary Dermatology Drugs Market – Segmentation

Product Type
  • Antifungal Drugs
  • Antibacterial Drugs
  • Antiparasitic Drugs
  • Others
Mode of Administration
  • Topical
  • Oral
  • Injectable
Animal Type
  • Large Animals
    • Equine
    • Bovine
    • Others
  • Small Animals
    • Cats
    • Dogs
    • Others
Indication
  • Infectious Diseases
  • Skin Cancer
  • Autoimmune Skin Diseases
  • Parasitic Infections
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Veterinary Dermatology Drugs Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of veterinary dermatology drugs market?

Veterinary dermatology drugs market to surpass valuation Of US$ 9.9 Bn by 2031

What are the key driving factors for the growth of the veterinary dermatology drugs market?

Veterinary dermatology drugs market is driven by increase in medical and diagnostic capabilities for companion animals

Which region is expected to project the highest market share in the global veterinary dermatology drugs market?

North America accounted for a major share of the global veterinary dermatology drugs market

Which is the rising prominent segment in the veterinary dermatology drugs market?

The antibacterial drugs segment dominated the global veterinary dermatology drugs market, owing to high prevalence of bacterial infection among animals

Who are the key players in the global veterinary dermatology drugs market?

Key players operating in the global veterinary dermatology drugs market are Merial, Zoetis, Inc., Ceva Sante Animale, Vetmedica, IDEXX Laboratories, Vetoquinol S.A.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Dermatology Drugs Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Veterinary Dermatology Drugs Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Regulatory Scenario by Region/globally

    5.3. Cost of Veterinary Dermatological treatments 

    5.4. List of Veterinary Dermatological Products Manufacturing Facilities, by Key Region 

    5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Product Type 

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        6.3.1. Antifungal Drugs

        6.3.2. Antibacterial Drugs

        6.3.3. Antiparasitic Drugs

        6.3.4. Others

    6.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type

7. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Mode of Administration

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        7.3.1. Topical

        7.3.2. Oral

        7.3.3. Injectable

    7.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration 

8. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Animal Type

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        8.3.1. Large Animals

            8.3.1.1. Equine

            8.3.1.2. Bovine

            8.3.1.3. Others

        8.3.2. Small Animals

            8.3.2.1. Cat

            8.3.2.2. Dogs

            8.3.2.3. Others

    8.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type

9. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Indication

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        9.3.1. Infectious Diseases

        9.3.2. Skin Cancer

        9.3.3. Autoimmune Skin Diseases

        9.3.4. Parasitic Infections

        9.3.5. Others

    9.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by  Indication

10. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Region 

    10.1. Key Findings

    10.2. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region

        10.2.1. North America

        10.2.2. Europe 

        10.2.3. Asia Pacific

        10.2.4. Latin America 

        10.2.5. Middle East & Africa

    10.3. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region

11. North America Veterinary Dermatology Drugs Market Analysis and Forecast

    11.1.  Introduction

        11.1.1.  Key Findings

    11.2. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        11.2.1. Antifungal Drugs

        11.2.2. Antibacterial Drugs

        11.2.3. Antiparasitic Drugs

        11.2.4. Others

    11.3. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        11.3.1. Oral

        11.3.2. Topical

        11.3.3. Injectable

    11.4. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        11.4.1. Large Animals

            11.4.1.1. Equine

            11.4.1.2. Bovine

            11.4.1.3. Others

        11.4.2. Small Animals

            11.4.2.1. Cat

            11.4.2.2. Dogs

            11.4.2.3. Others

    11.5. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        11.5.1. Infectious Diseases

        11.5.2. Skin Cancer

        11.5.3. Autoimmune Skin Diseases

        11.5.4. Parasitic Infections

        11.5.5. Others

    11.6. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Veterinary Dermatology Drugs Market Attractiveness Analysis

        11.7.1. By Product Type

        11.7.2. By Mode of Administration 

        11.7.3. By Animal Type

        11.7.4. By Indication

        11.7.5. By Country

12. Europe Veterinary Dermatology Drugs Market Analysis and Forecast

    12.1. Introduction

        12.1.1.  Key Findings

    12.2. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        12.2.1. Antifungal Drugs

        12.2.2. Antibacterial Drugs

        12.2.3. Antiparasitic Drugs

        12.2.4. Others

    12.3. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        12.3.1. Oral

        12.3.2. Topical

        12.3.3. Injectable

    12.4. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        12.4.1. Large Animals

            12.4.1.1. Equine

            12.4.1.2. Bovine

            12.4.1.3. Others

        12.4.2. Small Animals

            12.4.2.1. Cat

            12.4.2.2. Dogs

            12.4.2.3. Others

    12.5. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        12.5.1. Infectious Diseases

        12.5.2. Skin Cancer

        12.5.3. Autoimmune Skin Diseases

        12.5.4. Parasitic Infections

        12.5.5. Others

    12.6. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Veterinary Dermatology Drugs Market Attractiveness Analysis

        12.7.1. By Product Type

        12.7.2. By Mode of Administration 

        12.7.3. By Animal Type

        12.7.4. By Indication

        12.7.5. By Country/Sub-region

13. Asia Pacific Veterinary Dermatology Drugs Market Analysis and Forecast

    13.1. Introduction

        13.1.1.  Key Findings

    13.2. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        13.2.1. Antifungal Drugs

        13.2.2. Antibacterial Drugs

        13.2.3. Antiparasitic Drugs

        13.2.4. Others

    13.3. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        13.3.1. Oral

        13.3.2. Topical

        13.3.3. Injectable

    13.4. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        13.4.1. Large Animals

            13.4.1.1. Equine

            13.4.1.2. Bovine

            13.4.1.3. Others

        13.4.2. Small Animals

            13.4.2.1. Cat

            13.4.2.2. Dogs

            13.4.2.3. Others

    13.5. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        13.5.1. Infectious Diseases

        13.5.2. Skin Cancer

        13.5.3. Autoimmune Skin Diseases

        13.5.4. Parasitic Infections

        13.5.5. Others

    13.6. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India 

        13.6.4. Australia & New Zealand 

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis

        13.7.1. By Product Type

        13.7.2. By Mode of Administration 

        13.7.3. By Animal Type

        13.7.4. By Indication

        13.7.5. By Country/Sub-region

14. Latin America Veterinary Dermatology Drugs Market Analysis and Forecast

    14.1. Introduction

        14.1.1.  Key Findings

    14.2. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        14.2.1. Antifungal Drugs

        14.2.2. Antibacterial Drugs

        14.2.3. Antiparasitic Drugs

        14.2.4. Others

    14.3. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        14.3.1. Oral

        14.3.2. Topical

        14.3.3. Injectable

    14.4. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        14.4.1. Large Animals

            14.4.1.1. Equine

            14.4.1.2. Bovine

            14.4.1.3. Others

        14.4.2. Small Animals

            14.4.2.1. Cat

            14.4.2.2. Dogs

            14.4.2.3. Others

    14.5. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        14.5.1. Infectious Diseases

        14.5.2. Skin Cancer

        14.5.3. Autoimmune Skin Diseases

        14.5.4. Parasitic Infections

        14.5.5. Others

    14.6. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis

        14.7.1. By Product Type

        14.7.2. By Mode of Administration 

        14.7.3. By Animal Type

        14.7.4. By Indication

        14.7.5. By Country/Sub-region

15. Middle East & Africa Veterinary Dermatology Drugs Market Analysis and Forecast

    15.1. Introduction

        15.1.1.  Key Findings

    15.2. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

        15.2.1. Antifungal Drugs

        15.2.2. Antibacterial Drugs

        15.2.3. Antiparasitic Drugs

        15.2.4. Others

    15.3. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

        15.3.1. Oral

        15.3.2. Topical

        15.3.3. Injectable

    15.4. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

        15.4.1. Large Animals

            15.4.1.1. Equine

            15.4.1.2. Bovine

            15.4.1.3. Others

        15.4.2. Small Animals

            15.4.2.1. Cat

            15.4.2.2. Dogs

            15.4.2.3. Others

    15.5. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

        15.5.1. Infectious Diseases

        15.5.2. Skin Cancer

        15.5.3. Autoimmune Skin Diseases

        15.5.4. Parasitic Infections

        15.5.5. Others

    15.6. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries 

        15.6.2. South Africa 

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis

        15.7.1. By Product Type

        15.7.2. By Mode of Administration 

        15.7.3. By Animal Type

        15.7.4. By Indication

        15.7.5. By Country/Sub-region

16. Competitive Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

        16.2.1. Bayer

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Financial Overview

            16.2.1.3. Product Portfolio

            16.2.1.4. Strategic Overview

            16.2.1.5. SWOT Analysis

        16.2.2. Bimeda, Inc.

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Financial Overview

            16.2.2.3. Product Portfolio

            16.2.2.4. Strategic Overview

            16.2.2.5. SWOT Analysis

        16.2.3. Boehringer Ingelheim GmbH

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Financial Overview

            16.2.3.3. Product Portfolio

            16.2.3.4. Strategic Overview

            16.2.3.5. SWOT Analysis

        16.2.4. Ceva Santé Animale

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Financial Overview

            16.2.4.3. Product Portfolio

            16.2.4.4. Strategic Overview

            16.2.4.5. SWOT Analysis

        16.2.5. Eli Lilly and Company

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Financial Overview

            16.2.5.3. Product Portfolio

            16.2.5.4. Strategic Overview

            16.2.5.5. SWOT Analysis

        16.2.6. Merck Animal Health

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Financial Overview

            16.2.6.3. Product Portfolio

            16.2.6.4. Strategic Overview

            16.2.6.5. SWOT Analysis

        16.2.7. Sanofi S.A.

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Financial Overview

            16.2.7.3. Product Portfolio

            16.2.7.4. Strategic Overview

            16.2.7.5. SWOT Analysis

        16.2.8. Virbac

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Financial Overview

            16.2.8.3. Product Portfolio

            16.2.8.4. Strategic Overview

            16.2.8.5. SWOT Analysis

        16.2.9. Zoetis, Inc.

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Financial Overview

            16.2.9.3. Product Portfolio

            16.2.9.4. Strategic Overview

            16.2.9.5. SWOT Analysis

List of Tables

Table 01: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 03: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 04: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 05: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 06: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 07: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 09: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 10: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 11: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 12: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 13: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 14: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 15: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 17: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 18: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 19: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 20: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 21: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 22: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 23: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 24: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 25: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 26: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 27: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 28: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 29: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 30: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 31: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 32: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 33: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 34: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 35: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 36: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 37: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 38: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031

Table 39: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 40: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031

Table 41: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031

Table 42: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

List of Figures

Figure 01: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 03: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 04: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antifungal Drugs, 2017–2031

Figure 05: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antibacterial Drugs, 2017–2031

Figure 06: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antiparasitic Drugs, 2017–2031

Figure 07: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Others, 2017–2031

Figure 08: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 09: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 10: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Topical, 2017–2031

Figure 11: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Oral, 2017–2031

Figure 12: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Injectable, 2017–2031

Figure 13: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 14: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 15: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Large Animals, 2017–2031

Figure 16: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Small Animals, 2017–2031

Figure 17: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 18: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Figure 19: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031

Figure 20: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Skin Cancer, 2017–2031

Figure 21: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Autoimmune Skin Diseases, 2017–2031

Figure 22: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Parasitic Infections, 2017–2031

Figure 23: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Other, 2017–2031

Figure 24: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Region, 2020 and 2031

Figure 25: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region, 2021–2031

Figure 26: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 27: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Country, 2020 and 2031

Figure 28: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country, 2021–2031

Figure 29: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 30: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 31: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 32: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 33: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 34: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 35: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 36: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Figure 37: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 38: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 39: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 40: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 41: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 42: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 43: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 44: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 45: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 46: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 47: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Figure 48: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 49: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 50: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 51: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 52: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 53: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 54: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 55: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 56: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 57: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 58: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Figure 59: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 60: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 61: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 62: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 63: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 64: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 65: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 66: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 67: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 68: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 69: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Figure 70: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031

Figure 71: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 72: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 73: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 74: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 75: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031

Figure 76: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031

Figure 77: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031

Figure 78: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031

Figure 79: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031

Figure 80: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

855

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved